fto digital currency Top stories

Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.Twenty-five pilot banks in Shenzhen have opened a total of 64,000 cross-border wealth management accounts. The reporter was informed that by the end of November 2024, 25 pilot banks in Shenzhen had opened a total of 64,000 cross-border wealth management accounts, with a total amount of cross-border receipts and payments of 42.74 billion yuan, accounting for 48.1% and 44.2% of Guangdong-Hong Kong-Macao Greater Bay Area respectively.The plan for Indonesian civil servants to move to the new capital was postponed until April next year. On December 13th, local time, Diana Kusu Mastu, Deputy Minister of Public Works of Indonesia, said that the Indonesian government planned to move civil servants to the new capital Nusantara in April 2025. The construction of necessary infrastructure, including residential buildings, is under way, and the current construction progress has exceeded 60%. (CCTV News)

Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.European Central Bank Management Committee Muller: It is expected that Europe will recover slowly.Dongfang Zhizao recorded 7 boards in 9 days, and Dongfang Zhizao recorded 7 daily limit again, with a cumulative increase of 73.59% and a cumulative turnover rate of 262.35%. As of 14:05, the stock traded 353 million shares today, with a turnover of 2.753 billion yuan and a turnover rate of 27.62%. The total market value of the latest A shares reached 10.24 billion yuan, and the circulating market value of A shares was 10.24 billion yuan.

Market news: Israel said that the IDF will stay on the Syrian side of Mount Hermon for several months.Helen Piano's profit distribution plan for the first three quarters: it is planned to distribute 0.32 yuan for 10 shares, and Helen Piano (300329) released the profit distribution plan for the first three quarters of 2024 on the evening of December 13, and it is planned to distribute a cash dividend of 0.32 yuan (including tax) to all shareholders for every 10 shares, with an estimated cash dividend of 8,092,400 yuan.6 Lianban Yibin Paper: The company's current P/B ratio is quite different from that of the same industry. Yibin Paper announced the abnormal fluctuation of stock trading. Since December 6, 2024, the company's stock has been trading daily for six consecutive trading days, with a cumulative increase of 77.12%. According to the data released by CSI official website, the latest P/B ratio of papermaking and packaging owned by the company is 1.69 times, and the latest P/B ratio of the company is 9.28 times. The current P/B ratio of the company is quite different from that of the same industry. Investors are advised to pay attention to risks.